Framework agreement for the supply of MFR vaccine 2026 – 2030

Auto-translated from da

Original title: Rammekontrakt om levering af MFR-vaccine 2026 – 2030

Statens Serum Institut

Published: Aug 11, 2026

Updated: Aug 11, 2026

Source: TED - Tenders Electronic Daily (EU)

About This Opportunity

This is a supplies contract in the health and medical services sector. Located in Denmark, Europe, this opportunity is open to firms and consortiums. Proposals must be submitted before September 10, 2026.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

Original language: da

Rammeaftalen vedrører levering af MFR-vaccine (mæslinge-, fåresyge-, røde hunde-vaccine) i perioden 2026 – 2030. Det er et krav, at den tilbudte vaccine på tidspunktet for afgivelse af tilbud har markedsføringstilladelse gældende for Danmark, jf. Lægemiddellovens § 7, stk. 1. Yderligere krav til vaccinen fremgår af udbudsmaterialet. Det skønnes, at behovet for indkøb af MFR-vacciner som udgangspunkt er ca. 130.000 – 150.000 doser årligt, dvs. en samlet anslået mængde på ca. 520.000 – 600.000 doser rammeaftalens løbetid. Formålet med rammeaftalen er at sikre, at SSI kan foretage det fornødne indkøb af de omfattede vacciner til det offentlige vaccinationsprogram i overensstemmelse med det forventede behov for sådanne vacciner i rammeaftalens løbetid på op til 48 måneder. Indkøbet under aftalen afhænger af de beslutninger, der træffes for det offentlige vaccinationsprogram og af vaccinationstilslutningen. Der kan således forventes en væsentlig variation i årligt skønnet forbrug. Henset hertil og til at det samlede behov for vacciner kan variere betydeligt, afhængigt af hvilke beslutninger der træffes for det offentlige program, kan SSI samlet set købe op til 750.000 doser (den maksimale mængde) i henhold til rammeaftalen i dennes løbetid, jf. nærmere Appendix 2.

Data provenance

This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on August 11, 2026. Last refreshed today. Original language: da. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Statens Serum Institut

Statens Serum Institut has issued 8 procurement notices on BidsFactory, including 4 currently open and 2 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Research & Innovation. All notices are published for Denmark. Notices are distributed via TED - Tenders Electronic Daily (EU) and Denmark Udbud. Most recent publication: August 11, 2026.

Frequently asked questions about this tender

How can I submit a bid?

Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.

When does this tender close?

The submission deadline is September 10, 2026. You have 30 days left to prepare and submit your proposal to the contracting authority.

Who is the contracting authority?

This notice was issued by Statens Serum Institut in Denmark. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Where will the contract be performed?

The contract is for delivery in Denmark. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.